All Updates

BOISE, Idaho – June 2, 2026 – – The leadership of Sen. Mike Crapo in the introduction and passage of the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection (MCED) Screening Coverage Act was recognized recently by the American Cancer Society Cancer Action Network, in conjunction with 10 other organizations, in

The U.S. Centers for Medicare & Medicaid Services (CMS) released today an interim final rule on work requirement implementation in Medicaid.

Public health organizations across Arizona are raising concerns that HB 4001, which recently passed the Arizona Senate, leaves significant gaps in protecting kids from tobacco and nicotine products like e-cigarettes and nicotine pouches. The American Cancer Society Cancer Action Network (ACS CAN) along with the American Heart Association, American Lung

KNOXVILLE, Tenn. – May 28, 2026 – The Knoxville city council passed a smoke-free ordinance Tuesday night by a vote of 6-3. The ordinance will ensure thousands of Tennesseans can breathe clean, smoke-free air in most age-restricted venues. The American Cancer Society Cancer Action Network (ACS CAN) applauds the council

After months of debate, state lawmakers have finalized New York’s state budget, opting to preserve access to biomarker testing for Medicaid enrollees. The adopted budget changed language in the historic biomarker testing law, initially passed in 2023, to clarify biomarker testing is covered when it is medically necessary. The law will retain the most important criteria used for determining when testing is to be covered, drawing praise from cancer survivors and patient advocates.

Today, 60 organizations representing millions of cancer patients and survivors as well as the providers who care for them sent a letter to Health and Human Services (HHS) Secretary Kennedy conveying the importance of the US Preventive Services Task Force (USPSTF) in the fight against cancer and urging protection for the integrity of its work.

After months of debate, state lawmakers have finalized New York’s state budget, opting to preserve access to biomarker testing for Medicaid enrollees. The adopted budget changed language in the historic biomarker testing law, initially passed in 2023, to clarify biomarker testing is covered when it is medically necessary. The law will retain the most important criteria used for determining when testing is to be covered, drawing praise from cancer survivors and patient advocates.

Cancer Advocates Applaud the State Legislature's Passage of Biomarker Testing Legislation, Ensuring Illinoisans Have Better Access to Personalized Care.